II.2.2) Additional CPV code(s)

85323000

II.2.3) Place of performance

NUTS code:

UKH15

Main site or place of performance:

County Hall Martineau Lane

II.2.4) Description of the procurement

This notice is to communicate the intention to award a contract under the Provider Selection Regime (PSR) Competitive Process.<br/> <br/>NHS Norfolk and Waveney Integrated Care Board (now NHS Norfolk and Suffolk ICB) sought to procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>This is a 1 year contract with the option to extend for up to an additional 1 years. The 1 year contract value is a a maximum of £600,000. Any additional extensions are estimated to be £600,000 per annum a maximum contract value of £1,200,000 over the full 2 year contract period.<br/><br/>Service Description:<br/><br/>NHS Norfolk and Waveney Integrated Care Board (now NHS Norfolk and Suffolk ICB) is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

II.2.5) Award criteria

Quality criterion: Quality and Innovation / Weighting: 47

Quality criterion: Integration and Collaboration / Weighting: 25

Quality criterion: Social Value / Weighting: 10

Quality criterion: Improving access and reducing health inequalities / Weighting: 18

Cost criterion: Value / Weighting: 0

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 Regulations do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 4th June 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR.<br/><br/>The award decision has been made by the NHS Norfolk and Suffolk Executive team on the 27th April 2026.<br/><br/>There was one perceived Conflicts of interest identified which related to their role as an evaluator and their position as head of place development partnerships and planning. The Commissioner agreed this related to their professional role only and their participation in the process was as one of a number of evaluators, subject to a formal moderation process. <br/><br/>If you have wish to make a written representation regarding this intention to award please contact: procurement@snee.nhs.uk<br/><br/>The relative importance of the Key Criteria incorporated within the service was as follows:<br/>1. Quality and Innovation: 47.00%<br/>2. Value: Pass/Fail<br/>3. Integration, Collaboration & Service Sustainability: 25.00%<br/>4. Improving Access, Reducing Health Inequalities and Facilitating Choice: 18.00%<br/>5. Social Value: 10.00%<br/><br/>The relative importance of the Key Criteria was deemed appropriate based on the requirements of the service.<br/><br/>The rationale for awarding to the preferred provider was that they met all requirements associated with the Basic Selection Criteria and Key Criteria, clearly demonstrating their ability to deliver the requirements of the service within their submission, and they ranked as the highest scoring provider, based on their overall Key Criteria score, within this Provider Selection Process.

NHS England

Wellington House, 133-135 Waterloo Rd

London

SE1 8UG

UK

E-mail: england.commercialqueries@nhs.net

Internet address(es)

URL: https://www.england.nhs.uk/